S100A4 negatively regulates β-catenin by inducing the Egr-1-PTEN-Akt-GSK3β degradation pathway
- 1 October 2014
- journal article
- Published by Elsevier in Cellular Signalling
- Vol. 26 (10) , 2096-2106
Abstract
No abstract availableKeywords
Funding Information
- NRF (2013-059143)
- Korea Research Foundation
- Converging Research Center Program (2012-K001445)
This publication has 49 references indexed in Scilit:
- Metastasis promoter S100A4 is a potentially valuable molecular target for cancer therapyCancer Letters, 2009
- S100A4: a common mediator of epithelial–mesenchymal transition, fibrosis and regeneration in diseases?Journal of Molecular Medicine, 2008
- The S100A4 Metastasis Factor Regulates Cellular Motility via a Direct Interaction with Myosin-IIACancer Research, 2006
- S100A4, a Mediator of MetastasisJournal of Biological Chemistry, 2006
- Characterization of the Metastasis-associated Protein, S100A4Journal of Biological Chemistry, 2003
- Inhibitory Phosphorylation of Glycogen Synthase Kinase-3 (GSK-3) in Response to LithiumJournal of Biological Chemistry, 2003
- Intracellular and extracellular roles of S100 proteinsMicroscopy Research and Technique, 2003
- Interaction in Vivo and in Vitro of the Metastasis-inducing S100 Protein, S100A4 (p9Ka) with S100A1Journal of Biological Chemistry, 2000
- Identification and characterization of a fibroblast marker: FSP1.Journal of Cell Biology, 1995
- Binding of pEL98 protein, an S100-related calcium-binding protein, to nonmuscle tropomyosinJournal of Cell Biology, 1994